Patents by Inventor Satoshi Yamagoe

Satoshi Yamagoe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140242085
    Abstract: As a result of the analysis by an SST-REX method so as to identify a target molecule for treating and testing an Aspergillus fumigatus infection, a YMAF1 protein has been found out, which is mainly localized in the cell wall of Aspergillus fumigatus. Moreover, it has been found out that YMAF1 protein-deficient Aspergillus fumigatus has reduced spore-forming ability and pathogenicity. Further, it has been found out that the survival rate of experimental mice having aspergillosis (invasive Aspergillus model mice) is improved by preparing and administering an antibody against the YMAF1 protein. Furthermore, it has been found out that Aspergillus fumigatus can be detected with a favorable sensitivity by an ELISA system using the antibody.
    Type: Application
    Filed: August 12, 2011
    Publication date: August 28, 2014
    Applicants: MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., NATIONAL INSTITUTE OF INFECTIOUS DISEASES
    Inventors: Yoshitsugu Miyazaki, Satoshi Yamagoe, Masunori Kajikawa, Masahito Sugiura, Reiko Itoh, Hirotaka Kumagai
  • Patent number: 6723696
    Abstract: A leukocyte activating protein factor or a substance originating therein having an effect of inhibiting bone resorption; and novel medicinal utilization thereof. Use of these novel substances with the bone resorption inhibitory effect makes it possible to provide therapeutic methods efficacious against hypercalcemia, osteoporosis, etc.
    Type: Grant
    Filed: September 19, 2001
    Date of Patent: April 20, 2004
    Assignee: Japan as represented by Secretary of National Institute of Infectious Diseases
    Inventors: Kazuo Suzuki, Satoshi Yamagoe, Tooru Yamakawa
  • Patent number: 6541681
    Abstract: This invention relates to a mouse with deficiency of gene of neutrophil chemotactic factor LECT2 having a function of lacking by deleting a whole or a part LECT2 gene or inserting other gene such as a selective marker gene to any portion of the LECT2 gene or replacing it with another gene(s).
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: April 1, 2003
    Inventors: Satoshi Yamagoe, Kazuo Suzuki, Yoichiro Iwakura, Takeshi Saito, Masahide Asano
  • Patent number: 5929224
    Abstract: Human LECT2a polypeptide having amino acid sequence in the order shown in Sequence ID NOs. from 1 to 5, which did not include other proteins/peptides and human LECT2b polypeptide having amino acid sequence in the order shown Sequence ID NO. 6 in which did not include other proteins/peptides, and DNA coding LECT2b sequence.
    Type: Grant
    Filed: November 27, 1995
    Date of Patent: July 27, 1999
    Assignee: Kazuo Suzuki
    Inventors: Kazuo Suzuki, Satoshi Yamagoe, Yoshio Yamakawa, Satoshi Mizuno